Comments
Bio-pharmaceutical and health science sector representatives from the UK are to explore and expand partnerships with Indian companies.
Mr Ian Felton, British Deputy High Commissioner, Bangalore, said: “The UK-India Innovation and Leadership Meeting will be held at IIM, Bangalore, on March 5 and 6 to encourage IP-protected research and innovation in health science, explore entrepreneurial opportunities.”
“The visiting UK delegation is here to sign up a memorandum of understanding (MoU) with Indian counterparts to formalise their existing and fruitful science relationship,” he added.
UK representatives include Kings College London, Research Councils UK (RCUK), UK-India Business Council (UKIBC), Wellcome Trust, BioCity Nottingham and the University of Nottingham.
British companies attending include Critical Pharmaceuticals, UK, with a pipeline of novel biological products, Proxima Concepts, UK, offering oral delivery of peptides and proteins and technology for drug discovery, PGXis UK that is a genomics technology firm and Inception Associates UK that helps Indian firms in the sector, set up in the UK.
The 2012 Bio-Business Plan Competition is also being hosted by C-CAMP Bangalore and IIT Kanpur; finalists, who have attended a three-day Bio-Entrepreneurship and Business Development Training Programme delivered by BioCity Nottingham, will showcase their business concepts next week. The winner will receive a package of benefits worth around Rs 15 lakh to help them start a new company.
The meeting will showcase joint Indo-UK research, host winners of a bio-business plan competition and celebrate bio-entrepreneurial success stories in India.
“The meet will also discuss barriers and facilitators to innovation in the pharma industry and trends and developments in managing supply chains globally. I encourage Indian public and private research and development (R&D) institutions and entrepreneurs to come to the meeting and explore the potential to create new collaborations or expand existing links with the UK in this cutting-edge sector of bio-pharmaceuticals,” Mr Felton said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.